Anonymous
Guest
Anonymous
Guest
What is going on here. Is there a group of investors of which Valeant is part of?
Get ready for layoffs. Two Bausch reps and two Allergan reps per territory is too much
To buy something for the insane amount if money Valeant may have to fork up, certainly there will be Lay-offs, and synergies, especially the eye health business, so if you are in pharma, just watch out. Most of you know the recent history from last year, this adds more burden, but maybe it will be different this time. Who knows, we should find out tomorrow when the announcement happens. Wish all best of luck.
i'm scared
Get ready for layoffs. Two Bausch reps and two Allergan reps per territory is too much
In eye care allergan has 4 reps per territory.
4? I have two that I know of...four bc their territories are smaller than ours so we overlap two territories. They have glaucoma and allergy/dry eye.
This is very scary, indeed! If this acquisition happens, there is bound to be layoffs for Allergan & B&L reps.